AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Security National Financial Co Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

CVI Investments, Inc. and its investment manager Heights Capital Management, Inc. have filed a Schedule 13G reporting beneficial ownership of 2,110,200 Class A ordinary shares of Nano Labs Ltd (CUSIP G6391Y128). The position represents 9.9 % of the company’s 20,712,924 outstanding shares as stated in the issuer’s June 27 2025 prospectus supplement.

The stake comprises (i) 1.7 million shares already issued and (ii) additional shares issuable upon exercise of warrants. Each warrant contains a 9.99 % ownership blocker, preventing exercise that would push aggregate ownership above the 10 % threshold. Both entities report shared voting and dispositive power over the entire position; neither has sole voting or dispositive authority.

The reporting persons certify that the securities were not acquired to change or influence control of Nano Labs and disclaim beneficial ownership beyond their economic interest. Signatures were executed by Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, on July 1 2025.

  • Filing trigger date: June 26 2025
  • Reporting rule: 13d-1(c) passive investor filing
  • Jurisdictions: CVI (Cayman Islands); Heights Capital (Delaware, USA)

This disclosure informs the market that a single investment group has accumulated a stake just below the 10 % threshold—material information for assessing Nano Labs� shareholder base and potential future capital activity.

CVI Investments, Inc. e il suo gestore degli investimenti Heights Capital Management, Inc. hanno depositato un modulo Schedule 13G dichiarando la proprietà beneficiaria di 2.110.200 azioni ordinarie di Classe A di Nano Labs Ltd (CUSIP G6391Y128). La posizione rappresenta il 9,9% delle 20.712.924 azioni in circolazione della società, come indicato nel supplemento al prospetto del 27 giugno 2025 dell'emittente.

La partecipazione è composta da (i) 1,7 milioni di azioni già emesse e (ii) azioni aggiuntive emettibili tramite l'esercizio di warrant. Ogni warrant include una clausola che blocca la proprietà oltre il 9,99%, impedendo l'esercizio che porterebbe il possesso complessivo oltre il limite del 10%. Entrambe le entità riferiscono di avere potere condiviso di voto e disposizione sull'intera posizione; nessuna delle due detiene potere esclusivo di voto o disposizione.

Le persone che hanno presentato la dichiarazione certificano che i titoli non sono stati acquisiti per modificare o influenzare il controllo di Nano Labs e declinano la proprietà beneficiaria oltre al loro interesse economico. Le firme sono state apposte da Sarah Travis, Assistant General Counsel e Assistant Secretary di Heights Capital Management, il 1° luglio 2025.

  • Data di presentazione: 26 giugno 2025
  • Normativa di riferimento: 13d-1(c) dichiarazione da investitore passivo
  • Giurisdizioni: CVI (Isole Cayman); Heights Capital (Delaware, USA)

Questa comunicazione informa il mercato che un singolo gruppo di investimento ha accumulato una partecipazione appena sotto la soglia del 10% � un'informazione rilevante per valutare la base azionaria di Nano Labs e potenziali future attività di capitale.

CVI Investments, Inc. y su gestor de inversiones Heights Capital Management, Inc. han presentado un Schedule 13G reportando la propiedad beneficiaria de 2,110,200 acciones ordinarias Clase A de Nano Labs Ltd (CUSIP G6391Y128). La posición representa el 9.9% de las 20,712,924 acciones en circulación de la compañía, según se indica en el suplemento del prospecto del emisor fechado el 27 de junio de 2025.

La participación consta de (i) 1.7 millones de acciones ya emitidas y (ii) acciones adicionales que pueden emitirse mediante el ejercicio de warrants. Cada warrant contiene un bloqueo de propiedad del 9.99%, impidiendo el ejercicio que llevaría la propiedad agregada por encima del umbral del 10%. Ambas entidades reportan poder compartido de voto y disposición sobre toda la posición; ninguna tiene autoridad exclusiva de voto o disposición.

Las personas que reportan certifican que los valores no fueron adquiridos para cambiar o influir en el control de Nano Labs y rechazan la propiedad beneficiaria más allá de su interés económico. Las firmas fueron ejecutadas por Sarah Travis, Asistente del Consejero General y Secretaria Adjunta de Heights Capital Management, el 1 de julio de 2025.

  • Fecha de presentación: 26 de junio de 2025
  • Regla de reporte: 13d-1(c) presentación de inversionista pasivo
  • Jurisdicciones: CVI (Islas Caimán); Heights Capital (Delaware, EE.UU.)

Esta divulgación informa al mercado que un solo grupo de inversión ha acumulado una participación justo por debajo del umbral del 10% � información material para evaluar la base accionaria de Nano Labs y posibles futuras actividades de capital.

CVI Investments, Inc.와 ê·� íˆ¬ìž ê´€ë¦¬ìž Heights Capital Management, Inc.ëŠ� Nano Labs Ltd(CUSIP G6391Y128)ì� 2,110,200ì£� í´ëž˜ìŠ� A 보통ì£�ì—� 대í•� 실질 ì†Œìœ ê¶Œì„ ë³´ê³ í•˜ëŠ” Schedule 13Gë¥� 제출했습니다. ì� ì§€ë¶„ì€ ë°œí–‰ì‚¬ì˜ 2025ë…� 6ì›� 27ì¼ìž ë³´ì¶© ì„¤ëª…ì„œì— ëª…ì‹œë� 20,712,924ì£� 발행 주ì‹ì� 9.9%ì—� 해당합니ë‹�.

ì§€ë¶„ì€ (i) ì´ë¯¸ 발행ë� 170ë§� ì£�와 (ii) 워런íŠ� 행사 ì‹� 발행 가능한 추가 주ì‹ìœ¼ë¡œ 구성ë©ë‹ˆë‹�. ê°� 워런트ì—ëŠ� ì´� ì†Œìœ ê¶Œì´ 10%ë¥� 초과하지 않ë„ë¡� 9.99% 소유ê¶� 차단 ì¡°í•­ì� í¬í•¨ë˜ì–´ 있습니다. ë‘� 기관 ëª¨ë‘ ì „ì²´ ì§€ë¶„ì— ëŒ€í•� ê³µë™ ì˜ê²°ê¶� ë°� 처분ê¶�ì� 보고하며, ë‹¨ë… ì˜ê²°ê¶Œì´ë‚� ì²˜ë¶„ê¶Œì€ ì—†ìŠµë‹ˆë‹¤.

ë³´ê³ ìžëŠ” 해당 ì¦ê¶Œì� Nano Labsì� í†µì œê¶Œì„ ë³€ê²½í•˜ê±°ë‚˜ ì˜í–¥ 주기 위해 ì·¨ë“ë� ê²ƒì´ ì•„ë‹˜ì� ì¦ëª…하며, 경제ì � ì´ìµì� 초과하는 실질 ì†Œìœ ê¶Œì„ ë¶€ì¸í•©ë‹ˆë‹¤. ì„œëª…ì€ 2025ë…� 7ì›� 1ì� Heights Capital Managementì� 법률 ë¶€ì„� ë¶€ì´ê´„ 변호사 ê²� 부서기ì� Sarah Travisê°€ 수행했습니다.

  • ì‹ ê³  제출ì�: 2025ë…� 6ì›� 26ì�
  • ë³´ê³  규칙: 13d-1(c) ìˆ˜ë™ íˆ¬ìžìž� ì‹ ê³ 
  • ê´€í•� 구역: CVI(ì¼€ì´ë§¨ ì œë„); Heights Capital(미국 ë¸ë¼ì›¨ì–´)

ì´ë²ˆ 공시ëŠ� ë‹¨ì¼ íˆ¬ìž ê·¸ë£¹ì� 10% í•œë„ ë°”ë¡œ 아래까지 ì§€ë¶„ì„ ì¶•ì í–ˆìŒì� 시장ì—� 알리ëŠ� 것으ë¡�, Nano Labsì� 주주 구성ê³� 향후 ìžë³¸ í™œë™ í‰ê°€ì—� 중요í•� 정보입니ë‹�.

CVI Investments, Inc. et son gestionnaire d'investissement Heights Capital Management, Inc. ont déposé un Schedule 13G déclarant la propriété bénéficiaire de 2 110 200 actions ordinaires de Classe A de Nano Labs Ltd (CUSIP G6391Y128). Cette position représente 9,9 % des 20 712 924 actions en circulation selon le supplément du prospectus de l'émetteur en date du 27 juin 2025.

La participation comprend (i) 1,7 million d'actions déjà émises et (ii) des actions supplémentaires pouvant être émises à l'exercice des bons de souscription. Chaque bon de souscription contient un mécanisme bloquant la propriété au-delà de 9,99 %, empêchant tout exercice qui porterait la détention globale au-dessus du seuil de 10 %. Les deux entités déclarent détenir un pouvoir conjoint de vote et de disposition sur l'ensemble de la position ; aucune ne détient un pouvoir exclusif de vote ou de disposition.

Les déclarants certifient que les titres n'ont pas été acquis dans le but de modifier ou d'influencer le contrôle de Nano Labs et déclinent toute propriété bénéficiaire au-delà de leur intérêt économique. Les signatures ont été apposées par Sarah Travis, conseillère juridique adjointe et secrétaire adjointe de Heights Capital Management, le 1er juillet 2025.

  • Date de dépôt : 26 juin 2025
  • Règle de déclaration : 13d-1(c) déclaration d'investisseur passif
  • Juridictions : CVI (ÃŽles Caïmans) ; Heights Capital (Delaware, États-Unis)

Cette divulgation informe le marché qu'un seul groupe d'investissement a accumulé une participation juste en dessous du seuil de 10 % � une information importante pour évaluer la base d'actionnaires de Nano Labs et les potentielles futures opérations de capital.

CVI Investments, Inc. und ihr Investmentmanager Heights Capital Management, Inc. haben einen Schedule 13G eingereicht, der den wirtschaftlichen Eigentum an 2.110.200 Class A Stammaktien von Nano Labs Ltd (CUSIP G6391Y128) meldet. Die Position entspricht 9,9 % der 20.712.924 ausstehenden Aktien laut dem Nachtrag zum Prospekt des Emittenten vom 27. Juni 2025.

Der Anteil besteht aus (i) 1,7 Millionen bereits ausgegebenen Aktien und (ii) zusätzlichen Aktien, die durch Ausübung von Warrants ausgegeben werden können. Jeder Warrant enthält eine 9,99 %-Besitzsperre, die eine Ausübung verhindert, die das Gesamtbesitzverhältnis über die 10 %-Schwelle hinaus erhöhen würde. Beide Einheiten berichten über gemeinsame Stimm- und Verfügungsgewalt über die gesamte Position; keine verfügt über alleiniges Stimm- oder Verfügungsrecht.

Die meldenden Personen bestätigen, dass die Wertpapiere nicht zum Zweck der Kontrolle oder Einflussnahme auf Nano Labs erworben wurden und weisen wirtschaftliches Eigentum über ihr wirtschaftliches Interesse hinaus zurück. Die Unterschriften wurden am 1. Juli 2025 von Sarah Travis, Assistant General Counsel und Assistant Secretary von Heights Capital Management, geleistet.

  • Datum der Meldung: 26. Juni 2025
  • Meldevorschrift: 13d-1(c) passiver Investor
  • Jurisdiktionen: CVI (Kaimaninseln); Heights Capital (Delaware, USA)

Diese Offenlegung informiert den Markt darüber, dass eine einzelne Investmentgruppe eine Beteiligung knapp unterhalb der 10 %-Schwelle aufgebaut hat � eine wesentliche Information zur Bewertung der Aktionärsstruktur von Nano Labs und potenzieller zukünftiger Kapitalmaßnahmen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR � 9.9 % stake signals institutional interest but purposely stays under control threshold; neutral-to-modest positive for share-base stability.

From a capital-markets viewpoint, CVI/Heights� 9.9 % position adds a well-capitalized, professionally managed investor to Nano Labs� registry. The purchase, partially through warrants, provides flexibility while observing a 9.99 % blocker, indicating no near-term intent to cross into Schedule 13D territory. Although the filing does not disclose purchase price or intent, positions of this size can improve float liquidity and bolster perception of external confidence. However, outstanding warrants could introduce potential dilution if exercised. Overall, the development is noteworthy but not transformational; it neither alters control nor provides direct funding to the company.

TL;DR � Investor stays below 10 %, limiting governance influence; disclosure mainly affects ownership transparency.

By filing a passive Schedule 13G instead of a 13D, the group affirms it is not seeking to influence Nano Labs� strategy or board composition. The use of a warrant blocker further demonstrates intent to remain below the 10 % statutory threshold that often triggers additional governance scrutiny. Consequently, existing governance dynamics remain unchanged. Investors should nonetheless monitor subsequent filings; a conversion to 13D or ownership increases beyond 10 % would signal a shift toward activism or strategic involvement.

CVI Investments, Inc. e il suo gestore degli investimenti Heights Capital Management, Inc. hanno depositato un modulo Schedule 13G dichiarando la proprietà beneficiaria di 2.110.200 azioni ordinarie di Classe A di Nano Labs Ltd (CUSIP G6391Y128). La posizione rappresenta il 9,9% delle 20.712.924 azioni in circolazione della società, come indicato nel supplemento al prospetto del 27 giugno 2025 dell'emittente.

La partecipazione è composta da (i) 1,7 milioni di azioni già emesse e (ii) azioni aggiuntive emettibili tramite l'esercizio di warrant. Ogni warrant include una clausola che blocca la proprietà oltre il 9,99%, impedendo l'esercizio che porterebbe il possesso complessivo oltre il limite del 10%. Entrambe le entità riferiscono di avere potere condiviso di voto e disposizione sull'intera posizione; nessuna delle due detiene potere esclusivo di voto o disposizione.

Le persone che hanno presentato la dichiarazione certificano che i titoli non sono stati acquisiti per modificare o influenzare il controllo di Nano Labs e declinano la proprietà beneficiaria oltre al loro interesse economico. Le firme sono state apposte da Sarah Travis, Assistant General Counsel e Assistant Secretary di Heights Capital Management, il 1° luglio 2025.

  • Data di presentazione: 26 giugno 2025
  • Normativa di riferimento: 13d-1(c) dichiarazione da investitore passivo
  • Giurisdizioni: CVI (Isole Cayman); Heights Capital (Delaware, USA)

Questa comunicazione informa il mercato che un singolo gruppo di investimento ha accumulato una partecipazione appena sotto la soglia del 10% � un'informazione rilevante per valutare la base azionaria di Nano Labs e potenziali future attività di capitale.

CVI Investments, Inc. y su gestor de inversiones Heights Capital Management, Inc. han presentado un Schedule 13G reportando la propiedad beneficiaria de 2,110,200 acciones ordinarias Clase A de Nano Labs Ltd (CUSIP G6391Y128). La posición representa el 9.9% de las 20,712,924 acciones en circulación de la compañía, según se indica en el suplemento del prospecto del emisor fechado el 27 de junio de 2025.

La participación consta de (i) 1.7 millones de acciones ya emitidas y (ii) acciones adicionales que pueden emitirse mediante el ejercicio de warrants. Cada warrant contiene un bloqueo de propiedad del 9.99%, impidiendo el ejercicio que llevaría la propiedad agregada por encima del umbral del 10%. Ambas entidades reportan poder compartido de voto y disposición sobre toda la posición; ninguna tiene autoridad exclusiva de voto o disposición.

Las personas que reportan certifican que los valores no fueron adquiridos para cambiar o influir en el control de Nano Labs y rechazan la propiedad beneficiaria más allá de su interés económico. Las firmas fueron ejecutadas por Sarah Travis, Asistente del Consejero General y Secretaria Adjunta de Heights Capital Management, el 1 de julio de 2025.

  • Fecha de presentación: 26 de junio de 2025
  • Regla de reporte: 13d-1(c) presentación de inversionista pasivo
  • Jurisdicciones: CVI (Islas Caimán); Heights Capital (Delaware, EE.UU.)

Esta divulgación informa al mercado que un solo grupo de inversión ha acumulado una participación justo por debajo del umbral del 10% � información material para evaluar la base accionaria de Nano Labs y posibles futuras actividades de capital.

CVI Investments, Inc.와 ê·� íˆ¬ìž ê´€ë¦¬ìž Heights Capital Management, Inc.ëŠ� Nano Labs Ltd(CUSIP G6391Y128)ì� 2,110,200ì£� í´ëž˜ìŠ� A 보통ì£�ì—� 대í•� 실질 ì†Œìœ ê¶Œì„ ë³´ê³ í•˜ëŠ” Schedule 13Gë¥� 제출했습니다. ì� ì§€ë¶„ì€ ë°œí–‰ì‚¬ì˜ 2025ë…� 6ì›� 27ì¼ìž ë³´ì¶© ì„¤ëª…ì„œì— ëª…ì‹œë� 20,712,924ì£� 발행 주ì‹ì� 9.9%ì—� 해당합니ë‹�.

ì§€ë¶„ì€ (i) ì´ë¯¸ 발행ë� 170ë§� ì£�와 (ii) 워런íŠ� 행사 ì‹� 발행 가능한 추가 주ì‹ìœ¼ë¡œ 구성ë©ë‹ˆë‹�. ê°� 워런트ì—ëŠ� ì´� ì†Œìœ ê¶Œì´ 10%ë¥� 초과하지 않ë„ë¡� 9.99% 소유ê¶� 차단 ì¡°í•­ì� í¬í•¨ë˜ì–´ 있습니다. ë‘� 기관 ëª¨ë‘ ì „ì²´ ì§€ë¶„ì— ëŒ€í•� ê³µë™ ì˜ê²°ê¶� ë°� 처분ê¶�ì� 보고하며, ë‹¨ë… ì˜ê²°ê¶Œì´ë‚� ì²˜ë¶„ê¶Œì€ ì—†ìŠµë‹ˆë‹¤.

ë³´ê³ ìžëŠ” 해당 ì¦ê¶Œì� Nano Labsì� í†µì œê¶Œì„ ë³€ê²½í•˜ê±°ë‚˜ ì˜í–¥ 주기 위해 ì·¨ë“ë� ê²ƒì´ ì•„ë‹˜ì� ì¦ëª…하며, 경제ì � ì´ìµì� 초과하는 실질 ì†Œìœ ê¶Œì„ ë¶€ì¸í•©ë‹ˆë‹¤. ì„œëª…ì€ 2025ë…� 7ì›� 1ì� Heights Capital Managementì� 법률 ë¶€ì„� ë¶€ì´ê´„ 변호사 ê²� 부서기ì� Sarah Travisê°€ 수행했습니다.

  • ì‹ ê³  제출ì�: 2025ë…� 6ì›� 26ì�
  • ë³´ê³  규칙: 13d-1(c) ìˆ˜ë™ íˆ¬ìžìž� ì‹ ê³ 
  • ê´€í•� 구역: CVI(ì¼€ì´ë§¨ ì œë„); Heights Capital(미국 ë¸ë¼ì›¨ì–´)

ì´ë²ˆ 공시ëŠ� ë‹¨ì¼ íˆ¬ìž ê·¸ë£¹ì� 10% í•œë„ ë°”ë¡œ 아래까지 ì§€ë¶„ì„ ì¶•ì í–ˆìŒì� 시장ì—� 알리ëŠ� 것으ë¡�, Nano Labsì� 주주 구성ê³� 향후 ìžë³¸ í™œë™ í‰ê°€ì—� 중요í•� 정보입니ë‹�.

CVI Investments, Inc. et son gestionnaire d'investissement Heights Capital Management, Inc. ont déposé un Schedule 13G déclarant la propriété bénéficiaire de 2 110 200 actions ordinaires de Classe A de Nano Labs Ltd (CUSIP G6391Y128). Cette position représente 9,9 % des 20 712 924 actions en circulation selon le supplément du prospectus de l'émetteur en date du 27 juin 2025.

La participation comprend (i) 1,7 million d'actions déjà émises et (ii) des actions supplémentaires pouvant être émises à l'exercice des bons de souscription. Chaque bon de souscription contient un mécanisme bloquant la propriété au-delà de 9,99 %, empêchant tout exercice qui porterait la détention globale au-dessus du seuil de 10 %. Les deux entités déclarent détenir un pouvoir conjoint de vote et de disposition sur l'ensemble de la position ; aucune ne détient un pouvoir exclusif de vote ou de disposition.

Les déclarants certifient que les titres n'ont pas été acquis dans le but de modifier ou d'influencer le contrôle de Nano Labs et déclinent toute propriété bénéficiaire au-delà de leur intérêt économique. Les signatures ont été apposées par Sarah Travis, conseillère juridique adjointe et secrétaire adjointe de Heights Capital Management, le 1er juillet 2025.

  • Date de dépôt : 26 juin 2025
  • Règle de déclaration : 13d-1(c) déclaration d'investisseur passif
  • Juridictions : CVI (ÃŽles Caïmans) ; Heights Capital (Delaware, États-Unis)

Cette divulgation informe le marché qu'un seul groupe d'investissement a accumulé une participation juste en dessous du seuil de 10 % � une information importante pour évaluer la base d'actionnaires de Nano Labs et les potentielles futures opérations de capital.

CVI Investments, Inc. und ihr Investmentmanager Heights Capital Management, Inc. haben einen Schedule 13G eingereicht, der den wirtschaftlichen Eigentum an 2.110.200 Class A Stammaktien von Nano Labs Ltd (CUSIP G6391Y128) meldet. Die Position entspricht 9,9 % der 20.712.924 ausstehenden Aktien laut dem Nachtrag zum Prospekt des Emittenten vom 27. Juni 2025.

Der Anteil besteht aus (i) 1,7 Millionen bereits ausgegebenen Aktien und (ii) zusätzlichen Aktien, die durch Ausübung von Warrants ausgegeben werden können. Jeder Warrant enthält eine 9,99 %-Besitzsperre, die eine Ausübung verhindert, die das Gesamtbesitzverhältnis über die 10 %-Schwelle hinaus erhöhen würde. Beide Einheiten berichten über gemeinsame Stimm- und Verfügungsgewalt über die gesamte Position; keine verfügt über alleiniges Stimm- oder Verfügungsrecht.

Die meldenden Personen bestätigen, dass die Wertpapiere nicht zum Zweck der Kontrolle oder Einflussnahme auf Nano Labs erworben wurden und weisen wirtschaftliches Eigentum über ihr wirtschaftliches Interesse hinaus zurück. Die Unterschriften wurden am 1. Juli 2025 von Sarah Travis, Assistant General Counsel und Assistant Secretary von Heights Capital Management, geleistet.

  • Datum der Meldung: 26. Juni 2025
  • Meldevorschrift: 13d-1(c) passiver Investor
  • Jurisdiktionen: CVI (Kaimaninseln); Heights Capital (Delaware, USA)

Diese Offenlegung informiert den Markt darüber, dass eine einzelne Investmentgruppe eine Beteiligung knapp unterhalb der 10 %-Schwelle aufgebaut hat � eine wesentliche Information zur Bewertung der Aktionärsstruktur von Nano Labs und potenzieller zukünftiger Kapitalmaßnahmen.

false 0000318673 0000318673 2025-06-27 2025-06-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): June 27, 2025

 

SECURITY NATIONAL FINANCIAL CORPORATION

(Exact name of registrant as specified in this Charter)

 

Utah   000-09341   87-0345941
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

433 Ascension Way, 6th Floor, Salt Lake City, Utah   84123
(Address of principal executive offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (801) 264-1060

 

Does Not Apply

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol   Name of exchange on which registered
Class A Common Stock   SNFCA   The Nasdaq Global Select Market

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

The Annual Meeting of Stockholders (the “Annual Meeting”) of Security National Financial Corporation (the “Company”) was held on June 27, 2025, in Salt Lake City, Utah. As of April 21, 2025, the record date, there were issued and outstanding 21,324,826 shares of Class A common stock (including 1,012,466 shares of treasury stock) and 3,417,170 shares of Class C common stock (including 99,623 shares of treasury stock) for a total of 24,741,996 shares of the Company’s common stock outstanding. A majority of the outstanding shares of Class A and Class C common stock (or 11,814,954 shares) constituted a quorum for the transaction of business at the Annual Meeting. The Annual Meeting met the quorum requirements. A total of 19,756,812 shares were represented in person or by proxy and voted at the Annual Meeting, 16,468,953 shares of Class A common stock and 3,287,859 shares of Class C common stock, constituting in excess of majorities of each of those classes.

 

At the Annual Meeting, the Company’s stockholders (i) approved the election of Scott M. Quist, Robert G. Hunter M.D., Jason G. Overbaugh, Shital A. Mehta, John L. Cook, S. Andrew Quist, Gilbert A. Fuller, Adam G. Quist, and H. Craig Moody as directors of the Company; (ii) approved the amendment of the Company’s 2022 Equity Incentive Plan to authorize the issuance of an additional 3,000,000 shares of Class A and Class C common stock (out of which a maximum of 500,000 shares of Class C common stock may be issued); and (iii) ratified the appointment of Deloitte & Touche, LLP as the Company’s independent registered public accountants for the fiscal year ending December 31, 2025.

 

The results of the voting at the Annual Meeting on the matters submitted to the stockholders are set forth below. The voting results at the Annual Meeting set forth below reflect the weighted voting for the Class C common shares, which have a weighted voting of ten votes per share.

 

1. To elect three directors to be voted upon by the Class A common stockholders voting separately as a class to serve until the next Annual Meeting and until their successors are duly elected and qualified:

 

Name  Class  Votes For   Votes Withheld   Total 
Scott M. Quist  Class A   9,273,616    4,219,451    13,493,067 
Robert G. Hunter, M.D.  Class A   7,246,594    6,246,473    13,493,067 
Jason G. Overbaugh  Class A   9,268,391    4,224,676    13,493,067 

 

2. To elect the remaining six directors to be voted upon by the Class A and Class C common stockholders together to serve until the next Annual Meeting and until their successors are duly elected and qualified:

 

Name  Class  Votes For   Votes Withheld   Total 
Shital A. Mehta  Class A   7,758,279    5,734,788    13,493,067 
   Class C   32,878,590    -    32,878,590 
   Total   40,636,869    5,734,788    46,371,657 
                   
John L. Cook  Class A   7,758,396    5,734,671    13,493,067 
   Class C   32,878,590    -    32,878,590 
   Total   40,636,986    5,734,671    46,371,657 
                   
S. Andrew Quist  Class A   9,271,864    4,221,203    13,493,067 
   Class C   32,878,590    -    32,878,590 
   Total   42,150,454    4,221,203    46,371,657 
                   
Gilbert A. Fuller  Class A   7,201,812    6,291,255    13,493,067 
   Class C   32,878,590    -    32,878,590 
   Total   40,080,402    6,291,255    46,371,657 
                   
Adam G. Quist  Class A   9,270,648    4,222,419    13,493,067 
   Class C   32,878,590    -    32,878,590 
   Total   42,149,238    4,222,419    46,371,657 
                   
H. Craig Moody  Class A   6,971,732    6,521,335    13,493,067 
   Class C   32,878,590    -    32,878,590 
   Total   39,850,322    6,521,335    46,371,657 

 

 
 

 

3. To approve the amendment of the Company’s 2022 Equity Incentive Plan to authorize the issuance of an additional 3,000,000 shares of Class A and Class C common stock (out of which a maximum of 500,000 shares of Class C common stock may be issued).

 

Class  Votes For   Votes Against   Votes Abstaining 
Class A   9,116,402    4,360,047    16,618 
Class C   32,878,590    -    - 
Total   41,994,992    4,360,047    16,618 

 

4. To ratify the appointment of Deloitte & Touche, LLP as the Company’s independent registered public accountants for the year ending December 31, 2025:

 

Class  Votes For   Votes Against   Votes Abstaining 
Class A   16,398,503    67,981    2,469 
Class C   32,878,590    -    - 
Total   49,277,093    67,981    2,469 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

EXHIBIT NUMBER   DESCRIPTION
104   The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SECURITY NATIONAL FINANCIAL CORPORATION
  (Registrant)
     
Date: July 1, 2025 By: /s/ Scott M. Quist
    Scott M. Quist, Chairman, President and
    Chief Executive Officer

 

 

 

Security Natl

NASDAQ:SNFCA

SNFCA Rankings

SNFCA Latest News

SNFCA Latest SEC Filings

SNFCA Stock Data

237.28M
15.58M
30.12%
48.16%
0.07%
Mortgage Finance
Finance Services
United States
SALT LAKE CITY